Compare CFFN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFFN | QDEL |
|---|---|---|
| Founded | 1893 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 907.3M | 1.0B |
| IPO Year | 2010 | 2022 |
| Metric | CFFN | QDEL |
|---|---|---|
| Price | $7.25 | $17.20 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $7.25 | ★ $32.75 |
| AVG Volume (30 Days) | 890.1K | ★ 1.7M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | ★ 79.31 | 45.35 |
| EPS | ★ 0.16 | N/A |
| Revenue | $16,300,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $20.16 | $3.51 |
| Revenue Next Year | $6.62 | $3.86 |
| P/E Ratio | $45.31 | ★ N/A |
| Revenue Growth | ★ 6.54 | N/A |
| 52 Week Low | $4.90 | $14.45 |
| 52 Week High | $7.84 | $37.24 |
| Indicator | CFFN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 43.38 |
| Support Level | $6.02 | N/A |
| Resistance Level | $7.29 | $19.72 |
| Average True Range (ATR) | 0.15 | 1.25 |
| MACD | 0.03 | 0.36 |
| Stochastic Oscillator | 92.50 | 53.13 |
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.